Nishad Deshpande
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Nishad Deshpande has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Neha Mago
CSIR-Unit for Research and Development of Information Products (URDIP)
3 shared publications- Pratap Devarapalli
Department of Anatomy & Neurobiology, Northeast Ohio Medical University, 4209 St Rt 44, Rootstown, OH 44272, USA
2 shared publications Alok Khode
CSIR Unit Res & Dev Informat Prod, Pune, Maharashtra, India
1 shared publication- Alok Khode
Department of Informatics, CSIR Unit for Research and Development of Information Products, Pune, Maharashtra, India
1 shared publication Alok Khodea
CSIR Unit for Research and Development of Information Products ( CSIR URDIP) Pune India
1 shared publicationAsha Nagendra
Symbiosis Institute of Management Studies, Symbiosis International University, Pune, India
1 shared publication
Latest Publications
- 21 January 2026
- Published by Bentham Science Publishers Ltd. in Recent Advances in Anti-Infective Drug Discovery
- Vol. 21 (2) , 79-90
A Patent Review on the Use of Thymosin Peptides Against Viruses
Thymosins are a group of immunomodulatory peptides secreted by the thymus. They play an important role in immune function by inducing T-cell expression and inhibiting viral replication. In light of the COVID-19 pandemic caused by coronavirus, there has been renewed interest in their activity, resulting in a revival of patents claiming the use of thymosin to combat coronavirus. This article reviews patents on the therapeutic application of thymosin peptides against viruses. Conventionally, thymosin is administered via injection or infusion; however, recent research has explored alternative routes, including oral formulations. Thymosin administration is used to complement antiviral drug treatments. Similarly, recent antiviral regimens against SARS-CoV-2 may be supplemented with thymosin based on its proven immunopotentiating activity.
- 21 January 2026
- Published by Bentham Science Publishers Ltd. in Recent Advances in Anti-Infective Drug Discovery
- Vol. 21 (2) , 79-90
A Patent Review on the Use of Thymosin Peptides Against Viruses
Thymosins are a group of immunomodulatory peptides secreted by the thymus. They play an important role in immune function by inducing T-cell expression and inhibiting viral replication. In light of the COVID-19 pandemic caused by coronavirus, there has been renewed interest in their activity, resulting in a revival of patents claiming the use of thymosin to combat coronavirus. This article reviews patents on the therapeutic application of thymosin peptides against viruses. Conventionally, thymosin is administered via injection or infusion; however, recent research has explored alternative routes, including oral formulations. Thymosin administration is used to complement antiviral drug treatments. Similarly, recent antiviral regimens against SARS-CoV-2 may be supplemented with thymosin based on its proven immunopotentiating activity.
- 1 January 2023
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Annals of Library and Information Studies
- Vol. 70 (1) , 41-51-51
Topic modelling-based analysis of COVID-19 vaccine articles published in the preprint server MedRxiv
Two thousand one hundred and ninety-eight research publications on COVID-19 vaccines in MedRxiv preprintrepository during January 01, 2020 and December 31, 2021 were analyzed for topic modelling with unsupervised inferencemethod. Latent Dirichlet Allocation (LDA) method was used to investigate the thematic structure of the preprints. It wasobserved that the published articles were related to either clinical trials or patient responses to vaccine or modelling forvarious applications such as infection transmission, vaccine allocation, vaccine hesitancy etc.
- 1 January 2023
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Annals of Library and Information Studies
- Vol. 70 (1) , 41-51-51
Topic modelling-based analysis of COVID-19 vaccine articles published in the preprint server MedRxiv
Two thousand one hundred and ninety-eight research publications on COVID-19 vaccines in MedRxiv preprintrepository during January 01, 2020 and December 31, 2021 were analyzed for topic modelling with unsupervised inferencemethod. Latent Dirichlet Allocation (LDA) method was used to investigate the thematic structure of the preprints. It wasobserved that the published articles were related to either clinical trials or patient responses to vaccine or modelling forvarious applications such as infection transmission, vaccine allocation, vaccine hesitancy etc.
- Open Access
- 10 January 2018
- Published by University Nove de Julho in International Journal of Innovation
- Vol. 6 (1) , 33-39
Patent Data for Comparative Study: Case study of Top Aspirants in Bioinformatics Industry
Patent Data for Comparative Study: Case study of Top Aspirants in Bioinformatics Industry
- 10 January 2018
- Published by University Nove de Julho in International Journal of Innovation
- Vol. 6 (1) , 33-39
Open AccessPatent Data for Comparative Study: Case study of Top Aspirants in Bioinformatics Industry
Patent Data for Comparative Study: Case study of Top Aspirants in Bioinformatics Industry
- 1 December 2017
- Published by Elsevier in World Patent Information
- Vol. 51, 66-78
A landscape of bioinformatics patents - Garnering of IPR in the field of bioinformatics
- 1 December 2017
- Published by Elsevier in World Patent Information
- Vol. 51, 66-78
A landscape of bioinformatics patents - Garnering of IPR in the field of bioinformatics
- 7 June 2017
- Published by Springer Nature in Nature Biotechnology
- Vol. 35 (6) , 514-516
Patents as collateral for securitization
- 7 June 2017
- Published by Springer Nature in Nature Biotechnology
- Vol. 35 (6) , 514-516
Patents as collateral for securitization
- 16 January 2017
- Published by thinkBiotech, LLC in Journal of Commercial Biotechnology
- Vol. 22 (4)
Induced Pluripotent Stem Cells: Inventors turning into competitors
Induced Pluripotent Stem Cells (IPSCs) are a kind of adult cells that have been genetically reprogrammed to become different cell types. Differentiated cells can be reprogrammed to an embryonic-like state by transfer of nuclear contents into oocytes or by fusion with embryonic stem cells. IPSCs technology was pioneered by Shinya Yamanaka from Kyoto University. This breakthrough has inspired researchers to start working around IPSC technology. James Thomson from University of California has developed IPS cell lines derived from Human Somatic Cells. Subsequently, he also established a large scale human IPSC manufacturing company named Cellular Dynamics International. Thus, increasing interest in the commercial exploitation of IPSCs patents has lead us to look into the patent portfolios of top three patent assignees in IPSC technology. In this study, we have discussed technological patent trends and multiple factors which reflect the competitive scenario between the top assignees of IPSC technology. Our conclusions suggest that Kyoto University led by inventor Shinya Yamanaka is the leader of IPSC technology. However, patent-product linkage analysis suggests that Cellular Dynamics International led by inventor James Thomson may surpass Kyoto University in near future.
- 16 January 2017
- Published by thinkBiotech, LLC in Journal of Commercial Biotechnology
- Vol. 22 (4)
Induced Pluripotent Stem Cells: Inventors turning into competitors
Induced Pluripotent Stem Cells (IPSCs) are a kind of adult cells that have been genetically reprogrammed to become different cell types. Differentiated cells can be reprogrammed to an embryonic-like state by transfer of nuclear contents into oocytes or by fusion with embryonic stem cells. IPSCs technology was pioneered by Shinya Yamanaka from Kyoto University. This breakthrough has inspired researchers to start working around IPSC technology. James Thomson from University of California has developed IPS cell lines derived from Human Somatic Cells. Subsequently, he also established a large scale human IPSC manufacturing company named Cellular Dynamics International. Thus, increasing interest in the commercial exploitation of IPSCs patents has lead us to look into the patent portfolios of top three patent assignees in IPSC technology. In this study, we have discussed technological patent trends and multiple factors which reflect the competitive scenario between the top assignees of IPSC technology. Our conclusions suggest that Kyoto University led by inventor Shinya Yamanaka is the leader of IPSC technology. However, patent-product linkage analysis suggests that Cellular Dynamics International led by inventor James Thomson may surpass Kyoto University in near future.
- Open Access
- 30 December 2016
- Published by University of Latvia in Journal of Intelligence Studies in Business
- Vol. 6 (3) , 13-26
Business intelligence through patinformatics: A study of energy efficient data centres using patent data
The advent of cloud computing has nurtured an unprecedented growth of data centres. With its growth, the main concern for service providers and data centre owners is to efficiently manage the energy of the data centres without compromising their computing capabilities. This concern is genuine as data centres utilise 10-30 times more energy than office spaces and also generate immense heat. As cooling accounts for half of the total power consumption in data centres, efficient cooling systems have become a vital need for data centres. This has resulted in increased research and innovation in the field of efficient cooling of data centres, which in turn has led to growth in filing of patents in this domain. Patents are techno-legal documents that contain different kinds of information that is accessible to all. In the present study, patents are used as source of information for competitive/business intelligence to highlight the technological trends in the field of energy efficient cooling of data centres. The study reveals that IBM, HP, Schneider and Hon Hai Industries are the major players working in this technological area. Contrary to the notion that air conditioning would be the most researched area for cooling data centres, the study reveals that there is also interest in the hardware of the servers and racks to produce less heat or to have built-in cooling mechanisms. The main technologies for which patents are being filed include ventilation using gaseous coolant, technologies related to rack design as well as liquid cooling. Original equipment manufacturers and other vendors have increased filings, along with cloud service providers. Most of these technologies originate from Asia-Pacific and this region is a strong market, following the USA.
- 30 December 2016
- Published by University of Latvia in Journal of Intelligence Studies in Business
- Vol. 6 (3) , 13-26
Open AccessBusiness intelligence through patinformatics: A study of energy efficient data centres using patent data
The advent of cloud computing has nurtured an unprecedented growth of data centres. With its growth, the main concern for service providers and data centre owners is to efficiently manage the energy of the data centres without compromising their computing capabilities. This concern is genuine as data centres utilise 10-30 times more energy than office spaces and also generate immense heat. As cooling accounts for half of the total power consumption in data centres, efficient cooling systems have become a vital need for data centres. This has resulted in increased research and innovation in the field of efficient cooling of data centres, which in turn has led to growth in filing of patents in this domain. Patents are techno-legal documents that contain different kinds of information that is accessible to all. In the present study, patents are used as source of information for competitive/business intelligence to highlight the technological trends in the field of energy efficient cooling of data centres. The study reveals that IBM, HP, Schneider and Hon Hai Industries are the major players working in this technological area. Contrary to the notion that air conditioning would be the most researched area for cooling data centres, the study reveals that there is also interest in the hardware of the servers and racks to produce less heat or to have built-in cooling mechanisms. The main technologies for which patents are being filed include ventilation using gaseous coolant, technologies related to rack design as well as liquid cooling. Original equipment manufacturers and other vendors have increased filings, along with cloud service providers. Most of these technologies originate from Asia-Pacific and this region is a strong market, following the USA.
- 13 July 2016
- Published by Wiley in Biofuels, Bioproducts and Biorefining
- Vol. 10 (5) , 534-541
Xylose utilization in ethanol production: a patent landscape
Bioethanol is considered as one of the best alternatives to fossil fuels as unwanted biomass is converted into fuel ethanol. As there is increasing demand for fuel ethanol, researchers have started looking for some better ways to produce ethanol. In light of the present scenario, we have attempted to develop a global patent landscape view of xylose utilization in ethanol production. Our country‐specific patent analysis has revealed that most of the research on xylose‐utilizing ethanol production is carried out in the USA followed by China and Sweden. Moreover, it has been found that more patent applications/grants have been claimed for processes, followed by recombinant strains. Patent publication trends for genes and enzymes have shown that most of the research is focused on the xylA gene and xylulokinase. Assignee patenting trends suggest that Du Pont is the major player in xylose‐utilizing ethanol production research. Additionally, analysis based on micro‐organisms used in xylose‐utilizing ethanol production revealed that most of the research has been performed using Saccharomyces cerevisiae to enhance the ethanol yields. © 2016 Society of Chemical Industry and John Wiley & Sons, Ltd
- 13 July 2016
- Published by Wiley in Biofuels, Bioproducts and Biorefining
- Vol. 10 (5) , 534-541
Xylose utilization in ethanol production: a patent landscape
Bioethanol is considered as one of the best alternatives to fossil fuels as unwanted biomass is converted into fuel ethanol. As there is increasing demand for fuel ethanol, researchers have started looking for some better ways to produce ethanol. In light of the present scenario, we have attempted to develop a global patent landscape view of xylose utilization in ethanol production. Our country‐specific patent analysis has revealed that most of the research on xylose‐utilizing ethanol production is carried out in the USA followed by China and Sweden. Moreover, it has been found that more patent applications/grants have been claimed for processes, followed by recombinant strains. Patent publication trends for genes and enzymes have shown that most of the research is focused on the xylA gene and xylulokinase. Assignee patenting trends suggest that Du Pont is the major player in xylose‐utilizing ethanol production research. Additionally, analysis based on micro‐organisms used in xylose‐utilizing ethanol production revealed that most of the research has been performed using Saccharomyces cerevisiae to enhance the ethanol yields. © 2016 Society of Chemical Industry and John Wiley & Sons, Ltd
- 1 January 2015
- Published by Inderscience Publishers in International Journal of Intellectual Property Management
- Vol. 8 (3/4) , 135
Implementation of Dice coefficient to identify target for IP asset licensing
Licensing has proven to be most preferred way to recoup investments and make money out of business of inventing. The most crucial step of licensing process is picking the right company to license the invention. The present study relates to an analytical method that can be used by client organisation having single/set of patent(s) to identify target organisations that might be interested in licensing said patents. For this, the article uses Dice coefficient calculation using IPC as vector. More specifically, this method calculates Dice coefficient between client IPCs and target organisation IPCs to identify similarity and differences between their patent portfolios of a subject area. The ideal licensing deal can be made between those who have more in common or similarity per se. The method combines the significance of both similarity analysis and citation analysis for identifying licensing targets by overcoming some of the weaknesses inherent with citation analysis.
- 1 January 2015
- Published by Inderscience Publishers in International Journal of Intellectual Property Management
- Vol. 8 (3/4) , 135
Implementation of Dice coefficient to identify target for IP asset licensing
Licensing has proven to be most preferred way to recoup investments and make money out of business of inventing. The most crucial step of licensing process is picking the right company to license the invention. The present study relates to an analytical method that can be used by client organisation having single/set of patent(s) to identify target organisations that might be interested in licensing said patents. For this, the article uses Dice coefficient calculation using IPC as vector. More specifically, this method calculates Dice coefficient between client IPCs and target organisation IPCs to identify similarity and differences between their patent portfolios of a subject area. The ideal licensing deal can be made between those who have more in common or similarity per se. The method combines the significance of both similarity analysis and citation analysis for identifying licensing targets by overcoming some of the weaknesses inherent with citation analysis.